The outlook for the industry that helps pharmaceutical companies test experimental drugs, a mainstay of the Triangle economy, is more promising than it’s been since the recession slowed demand for such services.

Global revenue for contract research organizations is projected to climb 8.3 percent next year, up from an estimated 5 percent this year and 1.3 percent in 2010, according to William Blair & Co.

“There is no doubt that the industry is making a rebound,” said Jeff Williams, CEO of Clinipace Worldwide, a CRO with 175 employees, including 35 at its headquarters in Morrisville.

Back to Blog